サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1722517

不妊治療薬市場レポート：薬剤クラス別、投与経路別、流通チャネル別、エンドユーザー別、地域別、2025年～2033年

Infertility Drugs Market Report by Drug Class (Gonadotropin, Aromatase Inhibitors, Selective Estrogen Receptor Modulators, Biguanides, and Others), Route of Administration, Distribution Channel, End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 149 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.32円
不妊治療薬市場レポート：薬剤クラス別、投与経路別、流通チャネル別、エンドユーザー別、地域別、2025年～2033年
出版日: 2025年05月01日
発行: IMARC
ページ情報: 英文 149 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の不妊治療薬の市場規模は2024年に41億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに63億米ドルに達し、2025～2033年の成長率（CAGR）は4.49％になると予測しています。不妊率の増加、生殖補助医療技術（ART）の進歩、政府の支援策、医療費の増加、新薬開発、保険適用の可能性、不妊治療クリニックの急増などが市場開拓を加速させる要因となっています。

不妊治療薬は、不妊症の治療や個人の生殖機能を高めるために使用される様々な薬剤を指します。これらは注射または経口投与されます。一般的に使用される不妊治療薬には、ゴナドトロフィン、アロマターゼ阻害剤、選択的エストロゲン受容体モジュレーター（SERM）、ビグアナイド剤、排卵刺激剤、ドーパミン作動薬、三環系抗うつ剤などがあります。これらは、女性では卵巣の排卵と卵胞の開発を刺激することによって作用し、男性ではテストステロンレベルを回復させ、精子の質を向上させることによって妊娠をもたらします。近年、不妊治療薬は妊娠できないカップルの間で人気を集めています。

不妊治療薬の市場動向：

不妊治療薬は、妊娠に貢献する個人の能力を回復させることで、カップルの妊娠の可能性を高めます。その結果、不妊症や流産が増加し、市場の成長を促す主な要因となっています。これに加えて、利用可能な治療オプションに関する認識を広めるために各国政府が実施したいくつかの有利なイニシアチブが、不妊治療薬の需要を刺激しています。さらに、多忙な仕事のスケジュールやそれに伴うストレス、ライフスタイルの変化により、がん、肥満、糖尿病、甲状腺、多嚢胞性卵巣症候群（PCOS）、更年期障害などの慢性疾患の有病率が大幅に増加しています。これに加え、妊娠の遅れ、晩婚化、アルコールや薬物の過剰摂取、喫煙などの不健康な習慣による出生率の低下が、製品の採用率を加速させています。さらに、複数の主要企業が研究開発（R&D）活動に取り組んでおり、有効性が強化され、必要量が少なく、副作用の少ない革新的な不妊治療薬を発売しています。さらに、これらの医薬品開発のための公的資金の増加や、様々な規制機関からの迅速な医薬品承認が、市場の成長を後押ししています。ジェネリック医薬品への需要の高まり、ヘルスケアインフラの改善、消費支出能力の上昇、急速な都市化、技術の進歩など、その他の要因も市場成長を後押ししています。

本レポートで扱う主な質問

  • 不妊治療薬市場の規模は？
  • 不妊治療薬市場の将来展望は？
  • 不妊治療薬市場を牽引する主要因は何か？
  • 不妊治療薬市場で最大のシェアを占める地域は？
  • 世界の不妊治療薬市場における主要企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の不妊治療薬市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：薬剤クラス別

  • ゴナドトロピン
  • アロマターゼ阻害剤
  • 選択的エストロゲン受容体モジュレーター（SERM）
  • ビグアナイド
  • その他

第7章 市場内訳：投与経路別

  • 経口
  • 静脈内
  • 皮下
  • 筋肉内

第8章 市場内訳：流通チャネル別

  • 病院薬局
  • 小売薬局
  • その他

第9章 市場内訳：エンドユーザー別

  • 男性
  • 女性

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Bayer AG
    • Ferring Pharmaceuticals
    • Livzon Pharmaceutical Group Inc.
    • Mankind Pharma
    • Merck & Co. Inc.
    • Merck KGaA
    • Novartis AG
    • Pfizer Inc.
    • Sanofi S.A.
    • Theramex
図表

List of Figures

  • Figure 1: Global: Infertility Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Infertility Drugs Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Infertility Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Infertility Drugs Market: Breakup by Drug Class (in %), 2024
  • Figure 5: Global: Infertility Drugs Market: Breakup by Route of Administration (in %), 2024
  • Figure 6: Global: Infertility Drugs Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Infertility Drugs Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Infertility Drugs Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Infertility Drugs (Gonadotropin) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Infertility Drugs (Gonadotropin) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Infertility Drugs (Aromatase Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Infertility Drugs (Aromatase Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Infertility Drugs (Selective Estrogen Receptor Modulators (SERMs)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Infertility Drugs (Selective Estrogen Receptor Modulators (SERMs)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Infertility Drugs (Biguanides) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Infertility Drugs (Biguanides) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Infertility Drugs (Other Drug Classes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Infertility Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Infertility Drugs (Oral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Infertility Drugs (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Infertility Drugs (Intravenous) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Infertility Drugs (Intravenous) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Infertility Drugs (Subcutaneous) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Infertility Drugs (Subcutaneous) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Infertility Drugs (Intramuscular) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Infertility Drugs (Intramuscular) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Infertility Drugs (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Infertility Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Infertility Drugs (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Infertility Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Infertility Drugs (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Infertility Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Infertility Drugs (Male) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Infertility Drugs (Male) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Infertility Drugs (Female) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Infertility Drugs (Female) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: North America: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: North America: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: United States: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: United States: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Canada: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Canada: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Asia-Pacific: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Asia-Pacific: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: China: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: China: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Japan: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Japan: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: India: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: India: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: South Korea: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: South Korea: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Australia: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Australia: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Indonesia: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Indonesia: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Others: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Others: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Europe: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Europe: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Germany: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Germany: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: France: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: France: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: United Kingdom: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: United Kingdom: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Italy: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Italy: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Spain: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Spain: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Russia: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Russia: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Others: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Others: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Latin America: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Latin America: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Brazil: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Brazil: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Mexico: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Mexico: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Others: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Others: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Middle East and Africa: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Middle East and Africa: Infertility Drugs Market: Breakup by Country (in %), 2024
  • Figure 85: Middle East and Africa: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Global: Infertility Drugs Industry: SWOT Analysis
  • Figure 87: Global: Infertility Drugs Industry: Value Chain Analysis
  • Figure 88: Global: Infertility Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Infertility Drugs Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Infertility Drugs Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
  • Table 3: Global: Infertility Drugs Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
  • Table 4: Global: Infertility Drugs Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Infertility Drugs Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Infertility Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Infertility Drugs Market: Competitive Structure
  • Table 8: Global: Infertility Drugs Market: Key Players
目次
Product Code: SR112025A5239

The global infertility drugs market size reached USD 4.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.3 Billion by 2033, exhibiting a growth rate (CAGR) of 4.49% during 2025-2033. Increasing infertility rates, advancements in assisted reproductive technologies (ART), supportive government initiatives, rising healthcare expenditure, new pharmaceutical developments, availability of insurance coverage, and the proliferation of fertility clinics are some of the factors accelerating the market growth.

Infertility drugs refer to various medications used to treat infertility and enhance the reproductive health of an individual. They are either injected or taken orally. Some commonly used infertility drugs include gonadotrophins, aromatase inhibitors, selective estrogen receptor modulators (SERMs), biguanides, ovulatory stimulants, dopamine agonists, and tricyclic antidepressants. They work by stimulating ovulation and follicle development of the ovary in women, whereas they help restore testosterone levels and improve the quality of sperm in men to bring about pregnancy. In recent years, infertility drugs have gained traction among couples who are unable to conceive.

Infertility Drugs Market Trends:

Infertility drugs assist in enhancing the chances of pregnancy in couples by restoring the ability of an individual to contribute to conception. As a result, the rising incidences of infertility and miscarriage represents the primary factor driving the market growth. Besides this, several favorable initiatives undertaken by governments of various countries to spread awareness regarding the available treatment options are catalyzing the demand for infertility drugs. Additionally, there has been a significant increase in the prevalence of chronic diseases, such as cancer, obesity, diabetes, thyroid, polycystic ovarian syndrome (PCOS), and menopausal disorders, on account of hectic work schedules, accompanying stress, and lifestyle changes. Along with this, the declining fertility rates due to delayed pregnancies, late marriages, and unhealthy habits, such as excessive consumption of alcohol, drugs, and smoking, are accelerating the product adoption rates. Furthermore, several key players are engaging in research and development (R&D) activities to launch innovative infertility drugs with enhanced efficacy, lower dosage requirements, and fewer side effects. Moreover, the increasing public funding for developing these drugs and faster drug approvals from various regulatory bodies are propelling the market growth. Other factors, including the escalating demand for generic medicines, improving healthcare infrastructure, rising consumer expenditure capacities, rapid urbanization, and technological advancements, are also providing a positive thrust to the market growth.

Key Market Segmentation:

Breakup by Drug Class:

  • Gonadotropin
  • Aromatase Inhibitors
  • Selective Estrogen Receptor Modulators (SERMs)
  • Biguanides
  • Others

Breakup by Route of Administration:

  • Oral
  • Intravenous
  • Subcutaneous
  • Intramuscular

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

Breakup by End User:

  • Male
  • Female

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Bayer AG, Ferring Pharmaceuticals, Livzon Pharmaceutical Group Inc., Mankind Pharma, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Theramex.

Key Questions Answered in This Report

  • 1.How big is the infertility drugs market?
  • 2.What is the future outlook of infertility drugs market?
  • 3.What are the key factors driving the infertility drugs market?
  • 4.Which region accounts for the largest infertility drugs market share?
  • 5.Which are the leading companies in the global infertility drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Infertility Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Class

  • 6.1 Gonadotropin
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Aromatase Inhibitors
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Selective Estrogen Receptor Modulators (SERMs)
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Biguanides
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Intravenous
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Subcutaneous
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Intramuscular
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Male
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Female
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Bayer AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Ferring Pharmaceuticals
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Livzon Pharmaceutical Group Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Mankind Pharma
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Merck & Co. Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Merck KGaA
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Novartis AG
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Pfizer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Sanofi S.A.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Theramex
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio